Yasutaka Hayashi

1.4k total citations
24 papers, 829 citations indexed

About

Yasutaka Hayashi is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Yasutaka Hayashi has authored 24 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Hematology and 5 papers in Genetics. Recurrent topics in Yasutaka Hayashi's work include Acute Myeloid Leukemia Research (9 papers), Epigenetics and DNA Methylation (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Yasutaka Hayashi is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Epigenetics and DNA Methylation (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Yasutaka Hayashi collaborates with scholars based in Japan, United States and Taiwan. Yasutaka Hayashi's co-authors include Koji Tsuboi, Ayae Kanemoto, Yoshiko Oshiro, Hideyuki Sakurai, Masashi Mizumoto, Toshio Kitamura, H. Hashii, Nobuyoshi Fukumitsu, Takeji Sakae and Takayuki Hashimoto and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Blood.

In The Last Decade

Yasutaka Hayashi

24 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasutaka Hayashi Japan 14 303 275 225 172 150 24 829
Shichuan Zhang United States 6 243 0.8× 47 0.2× 346 1.5× 68 0.4× 60 0.4× 9 768
Clément Bailly France 22 229 0.8× 195 0.7× 219 1.0× 61 0.4× 25 0.2× 74 1.1k
Barbara Bachtiary Switzerland 18 241 0.8× 39 0.1× 259 1.2× 57 0.3× 36 0.2× 43 1.0k
Vittorio Donato Italy 15 110 0.4× 55 0.2× 250 1.1× 91 0.5× 11 0.1× 56 657
José C. Cruz United States 12 416 1.4× 436 1.6× 367 1.6× 349 2.0× 7 0.0× 31 1.2k
Kent P. Jensen United States 15 115 0.4× 107 0.4× 122 0.5× 34 0.2× 24 0.2× 22 1.2k
Paolo Borghetti Italy 18 155 0.5× 21 0.1× 442 2.0× 94 0.5× 21 0.1× 89 957
D. Skeggs United Kingdom 12 63 0.2× 361 1.3× 100 0.4× 72 0.4× 17 0.1× 18 708
Helena Garcia Schüler Switzerland 17 84 0.3× 33 0.1× 377 1.7× 31 0.2× 29 0.2× 41 784
J. Hoogenhout Netherlands 12 62 0.2× 219 0.8× 132 0.6× 67 0.4× 12 0.1× 37 546

Countries citing papers authored by Yasutaka Hayashi

Since Specialization
Citations

This map shows the geographic impact of Yasutaka Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasutaka Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasutaka Hayashi more than expected).

Fields of papers citing papers by Yasutaka Hayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasutaka Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasutaka Hayashi. The network helps show where Yasutaka Hayashi may publish in the future.

Co-authorship network of co-authors of Yasutaka Hayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasutaka Hayashi. A scholar is included among the top collaborators of Yasutaka Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasutaka Hayashi. Yasutaka Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Yasutaka, Koutarou Nishimura, Atsushi Tanaka, & Daichi Inoue. (2023). Extracellular vesicle-mediated remodeling of the bone marrow microenvironment in myeloid malignancies. International Journal of Hematology. 117(6). 821–829. 4 indexed citations
2.
Hayashi, Yasutaka, Susumu Goyama, Shuhei Asada, et al.. (2019). Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia. Nature Communications. 10(1). 4869–4869. 33 indexed citations
3.
Asada, Shuhei, Yasutaka Hayashi, Tomofusa Fukuyama, et al.. (2019). Opposing effects of acute versus chronic inhibition of p53 on decitabine’s efficacy in myeloid neoplasms. Scientific Reports. 9(1). 8171–8171. 6 indexed citations
4.
Fukushima, Tsuyoshi, Yosuke Tanaka, Fiona Hamey, et al.. (2019). Discrimination of Dormant and Active Hematopoietic Stem Cells by G0 Marker Reveals Dormancy Regulation by Cytoplasmic Calcium. Cell Reports. 29(12). 4144–4158.e7. 23 indexed citations
5.
Nagase, Reina, Daichi Inoue, Alessandro Pastore, et al.. (2018). Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation. The Journal of Experimental Medicine. 215(6). 1729–1747. 110 indexed citations
6.
Asada, Shuhei, Susumu Goyama, Daichi Inoue, et al.. (2018). Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis. Nature Communications. 9(1). 2733–2733. 85 indexed citations
7.
Kawabata, Kimihito C., Yasutaka Hayashi, Daichi Inoue, et al.. (2017). High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis. Leukemia. 32(2). 419–428. 7 indexed citations
8.
Hayashi, Yasutaka, Masashi Mizumoto, Hiroyoshi Akutsu, et al.. (2016). Hyperfractionated high-dose proton beam radiotherapy for clival chordomas after surgical removal. British Journal of Radiology. 89(1063). 20151051–20151051. 17 indexed citations
9.
Goyama, Susumu, Shiori Shikata, Yasutaka Hayashi, et al.. (2016). Inhibition of Impdh As an Effective Treatment for MLL-Fusion Leukemia. Blood. 128(22). 750–750. 2 indexed citations
10.
Hayashi, Yasutaka, Ying Zhang, Goro Sashida, et al.. (2015). 70 IDENTIFICATION AND TARGETING HIF-1A PATHWAY IN MDS DEVELOPMENT AND MAINTENANCE. Leukemia Research. 39. S34–S35. 1 indexed citations
11.
Inoue, Daichi, Jiro Kitaura, Hirotaka Matsui, et al.. (2014). SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS. Leukemia. 29(4). 847–857. 52 indexed citations
12.
Inoue, Daichi, Hirotaka Matsui, Hsin‐An Hou, et al.. (2014). SETBP1 Mutations Drive Leukemic Transformation in ASXL1-Mutated MDS. Blood. 124(21). 525–525. 3 indexed citations
13.
Fukumitsu, Nobuyoshi & Yasutaka Hayashi. (2014). Application of a deformable registration technique to investigate breath-hold reproducibility. Japanese Journal of Radiology. 32(12). 700–707. 3 indexed citations
14.
Mizumoto, Masashi, Toshiyuki Okumura, Takayuki Hashimoto, et al.. (2012). Evaluation of Liver Function After Proton Beam Therapy for Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 82(3). e529–e535. 54 indexed citations
15.
Sato, Motohiro, et al.. (2011). Collision Lung Cancer on F-18 FDG PET/CT. Clinical Nuclear Medicine. 36(8). e98–e100. 1 indexed citations
16.
Mizumoto, Masashi, Toshiyuki Okumura, Takayuki Hashimoto, et al.. (2010). Proton Beam Therapy for Hepatocellular Carcinoma: A Comparison of Three Treatment Protocols. International Journal of Radiation Oncology*Biology*Physics. 81(4). 1039–1045. 129 indexed citations
17.
Sato, Motohiro, et al.. (2009). Usefulness of F-18 FDG PET/CT in the assessment of disseminated Mycobacterium avium complex infection. Annals of Nuclear Medicine. 23(8). 757–762. 13 indexed citations
18.
Mizumoto, Masashi, Koji Tsuboi, Hiroshi Igaki, et al.. (2009). Phase I/II Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme. International Journal of Radiation Oncology*Biology*Physics. 77(1). 98–105. 75 indexed citations
19.
Oshiro, Yoshiko, Shinji Sugahara, Mio Noma, et al.. (2008). Proton Beam Therapy Interference With Implanted Cardiac Pacemakers. International Journal of Radiation Oncology*Biology*Physics. 72(3). 723–727. 40 indexed citations
20.
Ohnìshì, H., Kohmei Ida, Tomohiko Taki, et al.. (1997). Alterations of p16 and p15 genes in acute leukemia with MLL gene rearrangements and their correlation with clinical features. Leukemia. 11(12). 2120–2124. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shichuan Zhang Breakdown of academic impact, for papers by Clément Bailly Breakdown of academic impact, for papers by Barbara Bachtiary Breakdown of academic impact, for papers by Vittorio Donato Breakdown of academic impact, for papers by José C. Cruz Breakdown of academic impact, for papers by Kent P. Jensen Breakdown of academic impact, for papers by Paolo Borghetti Breakdown of academic impact, for papers by D. Skeggs Breakdown of academic impact, for papers by Helena Garcia Schüler Breakdown of academic impact, for papers by J. Hoogenhout
Rankless by CCL
2026